Simona Stolnicu studied medicine and graduated from the University of Medicine and Pharmacy of Iasi, Romania, in 1991. She became Assistant Professor in 1993, completed pathology residency training, and received her PhD in Medicine at the University of Medicine, Pharmacy, Sciences and Technology of Targu Mures (UMFST), Romania. She completed her training in gynecologic and breast pathology as a fellow/ observer at University of Granada, Spain; University of Trieste, Italy; MD Anderson Cancer Center, Houston, USA; and Memorial Sloan Kettering Cancer Center, New York, USA. Since 1997, she is a consultant pathologist at the Department of Pathology, UMFST, Romania, specialized in the diagnosis of gynecologic and breast diseases. She is also a Professor of Pathology at the same university, teaching students, residents, and PhD students for three decades. She was an invited Lecturer and Course Director of continuing education courses on gynecologic and breast pathology offered by national (Eurogynpath) and international (European Society of Pathology, Canadian Association of Pathologists, International Academy of Pathology, International Gynecologic Cancer Society, American Society of Clinical Pathologists, Latin American Society of Pathology, International Society of Gynecological Pathologists) medical organizations. She was Secretary (2013-2016) and Chair (2017-2021) of Gynecologic Pathology Working Group of the European Society of Pathology (ESP) serving on abstract review and scientific committees regarding the ESP activities. She is currently member of International Society of Gynecologic Pathologists (ISGyP) Global Advisory Network, Officer-at Large on the Board Committee of ISGyP, and member of Financing Committee of ISGyP. Dr. Stolnicu actively worked to finalize the Memorandum of Understanding (MoU) between the ESP and ISGyP. She works as part of Project ECHO, a joint educational venture of International Gynecologic Cancer Society and ISGyP, serving as a pathology mentor through remote sessions with cancer centers in Caribbean countries. She is also a member of the expert panel of International Collaboration on Cancer Reporting (ICCR) Carcinoma of the Cervix dataset and a member of the Pathology National Committee in Romania. She serves as a member of editorial board and/or reviewer for many peer-reviewed journals, has authored and coauthored more than 400 publications in indexed, peer-reviewed journals, and is editor/author of 25 medical books in the field of gynecologic and breast pathology, including the 2020 WHO classification of the female genital tract tumors.

Rouba Ali-Fehmi is a Professor of Pathology and the Director of Breast Pathology and Breast Pathology Fellowship at the University of Michigan. She is also a member of Global Reach at Michigan Medicine and a member of the Center of Global Health Equity at the University of Michigan. She previously acted as Vice Chair of the Department of Pathology atKarmanos Cancer Institute and Wayne State University, where she also served as the Surgical Pathology Fellowship Director. Dr. Ali-Fehmi serves as a UNICEF USA Midwest board member and is an active member of multiple national and international professional societies. She is also the former president of the Michigan Society of Pathologists (2012 -2014). Dr. Ali-Fehmi is very interested and dedicated to teaching and research. Over the course of her career, she has mentored many gynecologic oncology and pathology fellows, which ultimately led to more than 140 peer-reviewed publications and presentations, both at national and international meetings. Her research has received many NIH grants in breast and GYN pathology. She is also very active in the International Academy of Pathology - Arab Division, where she gives interactive lectures and workshops in most Arab countries. Dr. Ali-Fehmi has served as the liaison to the Middle East at the Global Health Research Collaborative at WayneState University, where in 2010, she established a Clinical Training Research Associate (CTRA) program, which empowers selected IMGs from predominantly middle- and lower-income Middle Eastern countries by spending 1 -2 years focusing on clinical scientific research. This CTRA program has helped over 36 young doctors match into residency programs, all of whom went on to subsequently work and specialize in different locations around the country and overseas. Dr. Ali-Fehmi is also the former president of the National Arab American Medical Association (NAAMA) and the founder and current chair of NAAMA NextGen. She has also pioneered many research studies to investigate medical and health-related topics in the Arab American population, including obesity in the Arab American population, the rate of HPV in Arab American women, and COVID-19 vaccine attitudes among Arab Americans which was presented at the White House. Dr. Ali-Fehmi together with NextGen students has supported Syrian refugees'education, highlighted by the "Keys for Syrian Kids " project.

Abnormal (nonmolar) villous lesions, Pathology of the placenta.- Adenocarcinoma and precursors, Pathology of the cervix.- Benign epithelial tumors and tumor-like lesions, Pathology of the cervix.- Benign epithelial tumors and tumor-like lesions, Pathology of the vulva.- Benign glandular lesions, Pathology of the vagina.- Benign squamous lesions, Pathology of the vagina.- Benign Tumors, Pathology of the broad ligament and other uterine ligaments.- Benign tumors, Pathology of the fallopian tube.-Benign tumors, Pathology of the peritoneum.- Brenner tumors, Pathology of the ovary.- Clear cell tumors, Pathology of the ovary.- Endometrioid tumors, Pathology of the ovary.- Epithelial tumors and precursors, Type 1.- Epithelial tumors and precursors, Type 2.- Epithelial tumors and precursors, Type 2: Pathology of the uterine corpus.